JPS6058904B2 - Novel cyclohexanecarboxylic acid amide derivative - Google Patents
Novel cyclohexanecarboxylic acid amide derivativeInfo
- Publication number
- JPS6058904B2 JPS6058904B2 JP9401178A JP9401178A JPS6058904B2 JP S6058904 B2 JPS6058904 B2 JP S6058904B2 JP 9401178 A JP9401178 A JP 9401178A JP 9401178 A JP9401178 A JP 9401178A JP S6058904 B2 JPS6058904 B2 JP S6058904B2
- Authority
- JP
- Japan
- Prior art keywords
- acid amide
- acid
- methyl
- melting point
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical class NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 title claims description 6
- 239000000126 substance Substances 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 238000002844 melting Methods 0.000 description 21
- 230000008018 melting Effects 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000000862 absorption spectrum Methods 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 12
- 238000001819 mass spectrum Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- -1 1-methyl-4-isohexylcyclohexane Chemical compound 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 239000000043 antiallergic agent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- HARNFRANZLWZKO-UHFFFAOYSA-N 1-methyl-4-(4-methylpentyl)cyclohexane-1-carboxylic acid Chemical compound CC(C)CCCC1CCC(C)(C(O)=O)CC1 HARNFRANZLWZKO-UHFFFAOYSA-N 0.000 description 2
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000005379 cyclohexanecarboxylic acid derivatives Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- BMEVZVXFJBPTKE-UHFFFAOYSA-N 1-hexylcyclohexane-1-carboxylic acid Chemical compound CCCCCCC1(C(O)=O)CCCCC1 BMEVZVXFJBPTKE-UHFFFAOYSA-N 0.000 description 1
- BKRNGBZBKWSHTC-UHFFFAOYSA-N 1-tert-butylcyclohexane-1-carboxamide Chemical compound CC(C)(C)C1(C(N)=O)CCCCC1 BKRNGBZBKWSHTC-UHFFFAOYSA-N 0.000 description 1
- IFXKXCLVKQVVDI-UHFFFAOYSA-N 2-amino-5-chlorobenzoic acid Chemical compound NC1=CC=C(Cl)C=C1C(O)=O IFXKXCLVKQVVDI-UHFFFAOYSA-N 0.000 description 1
- BALGERHMIXFENA-UHFFFAOYSA-N 4-butylcyclohexane-1-carboxylic acid Chemical compound CCCCC1CCC(C(O)=O)CC1 BALGERHMIXFENA-UHFFFAOYSA-N 0.000 description 1
- UNROFSAOTBVBBT-UHFFFAOYSA-N 4-ethylcyclohexane-1-carboxylic acid Chemical compound CCC1CCC(C(O)=O)CC1 UNROFSAOTBVBBT-UHFFFAOYSA-N 0.000 description 1
- RVLAXPQGTRTHEV-UHFFFAOYSA-N 4-pentylcyclohexane-1-carboxylic acid Chemical compound CCCCCC1CCC(C(O)=O)CC1 RVLAXPQGTRTHEV-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000244188 Ascaris suum Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- RHMQNXNXUZLEIY-UHFFFAOYSA-N methanol;2-propan-2-yloxypropane Chemical compound OC.CC(C)OC(C)C RHMQNXNXUZLEIY-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は一般式(I)
R1、CONHA
[ζ〕
(I)
、、、、−H一
ロゲン原子、水酸基、カルボキシル基又は低級アルコキ
シカルボニル基が任意の位置に1〜3個置換したフェニ
ル基又はピリジル基を、Rは低級アルキル基を、R゛は
水素原子又はメチル基を意味する)で表わされる新規な
シクロヘキサンカルボン酸アミド誘導体に関するもので
ある。DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula (I) R1, CONHA [ζ] (I) , , -H, in which a halogen atom, hydroxyl group, carboxyl group or lower alkoxycarbonyl group is present at any position from 1 to The present invention relates to a novel cyclohexanecarboxylic acid amide derivative represented by a phenyl group or a pyridyl group substituted with three members, R representing a lower alkyl group, and R′ representing a hydrogen atom or a methyl group.
前記一般式(1)におけるA及びRについて更に具体的
に説明すると、Aはメチル、エチル、n−プロピル、イ
ソプロピル、n−ブチル、イソブチル・及びtert−
ブチル等の炭素数1〜4からなる低級アルコキシカルボ
ニル基が任意の位置に1〜3個置換したフェニル基又は
ピリジル基を、Rの低級アルキル基はメチル、エチル、
n−ブロピル、イソプロピル、n−ブチル、イソブチル
、n−ペン・チル、イソペンチル、n−ヘキシル及びイ
ソヘキシル等の低級アルキル基を表わす。To explain A and R in the general formula (1) more specifically, A represents methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, and tert-
The lower alkyl group of R is methyl, ethyl,
Represents a lower alkyl group such as n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, n-hexyl, and isohexyl.
従来、抗原抗体反応により惹起されるケミカルメデイエ
ーターの遊離を抑制する抗アレルギー剤としてはジソジ
ウムクロモグリケート (商品名イフンタール)が知ら
れているが、このものは経口投与では薬効を奏しないた
め、その使用にはいろいろ制限があつた。Disodium cromoglycate (trade name: Ifuntal) has been known as an anti-allergic agent that suppresses the release of chemical mediators caused by antigen-antibody reactions, but this drug has no medicinal effect when administered orally. There were various restrictions on its use.
従つて経口投与によつても十分な治療効果を有する抗ア
レルギー剤の開発が強く要望されているわけである。そ
こで本発明者等は丁経口投与て薬効を奏する抗アレルギ
ー剤の開発を目的として一連の新規なシクロヘキサンカ
ルボン酸アミド誘導体の合成を行なつた。本発明によつ
て得られる新規なシクロヘキサンカルボン酸アミド誘導
体はすぐれた抗アレルギー作用を有し、しかも経口投与
においても顕著な薬効を有し、医薬品として有用な化合
物である。Therefore, there is a strong demand for the development of antiallergic agents that have sufficient therapeutic effects even when administered orally. Therefore, the present inventors synthesized a series of novel cyclohexanecarboxylic acid amide derivatives with the aim of developing an antiallergic agent that is effective when administered orally. The novel cyclohexanecarboxylic acid amide derivative obtained by the present invention has an excellent antiallergic effect and also has remarkable medicinal efficacy even when administered orally, making it a useful compound as a pharmaceutical.
以下に本発明のもつ抗アレルギー作用を薬理実験によつ
て示す。実験法
ラットでのホモロガス受身皮膚反応
Tada..Tetal(Tada,.T.&0kum
ura..J.ImmurK)1..昶休1002、1
971)の方法に準拠してホモロガス受身皮膚アナフイ
ラキシー反応(HOmOlOg..PCA)を170〜
190fのウイスター系雄ラットで試験した。The antiallergic effect of the present invention will be shown below through pharmacological experiments. Experimental method Homologous passive skin reaction in rats Tada. .. Tetal(Tada,.T.&0kum
ura. .. J. ImmurK)1. .. Shokyu 1002, 1
Homologous passive cutaneous anaphylaxis reaction (HOmOlOg..PCA) according to the method of 971)
Tested in 190f Wistar male rats.
即ち、プタ回虫(Ascarissuum)の抽出蛋白
にジニトロフエノール(DNP)を反応させDNP−A
s(Dlnitr′0pheny1c0np1edAs
carissuuTnextract)を得てこれを抗
原とした。この抗原によつて抗DNP−Asラット血清
を作製し抗体とした。この充分なり価を有する抗体をラ
ットの除毛背部皮内に一側に3ケ所0.1mt1sit
eずつ注射し、他側3ケ所には生理食塩液を0.1mt
1site皮内注射して実験過誤のチェックをした。招
時間後に0.25%エバンス・ブルーを含む抗原(蛋白
量として2.0m9)液1.0m1Iratを静脈注射
した。自分後にラットを放血致死させ剥皮を行なつて色
素漏出面積の長径と短径の積を浸出係数(PI)とし、
又Harada..M.etal(HaradalM.
、Takeuchi..M.、FukaOlT.&Ka
tagiri..K.;J.pharm.pharma
cOl.、?218.1971)の方法で.漏出色素量
を測定した。薬物は抗原投与の2時間前に2000m9
1k9を経口投与した。That is, dinitrophenol (DNP) is reacted with the extracted protein of Ascarissuum to form DNP-A.
s(Dlnitr'0pheny1c0np1edAs
carissuuTnextract) and used it as an antigen. Anti-DNP-As rat serum was prepared using this antigen and used as an antibody. Apply this antibody with sufficient titer to the hairless back skin of a rat at 0.1 mt/sit in 3 locations on one side.
Inject 0.1 mt of physiological saline in 3 places on the other side.
One site was injected intradermally to check for experimental errors. After the invitation time, 1.0 ml of an antigen solution (2.0 ml of protein) containing 0.25% Evans Blue was intravenously injected. The rats were then exsanguinated and skinned, and the product of the major axis and minor axis of the dye leakage area was determined as the percolation coefficient (PI).
Also Harada. .. M. etal (HaradalM.
, Takeuchi. .. M. , FukaOlT. &Ka
tagiri. .. K. ;J. pharm. pharma
cOl. ,? 218.1971) method. The amount of leaked dye was measured. The drug was administered at 2000 m9 2 hours before antigen administration.
1k9 was administered orally.
以上の薬理実験の結果より本発明の化合物は優れた抗ア
レルギー作用を有し、しかも経口投与で有効であること
が判明した。The results of the above pharmacological experiments revealed that the compound of the present invention has an excellent antiallergic effect and is effective when administered orally.
ノ 次に本発明の化合物の製造法に就いて説明するがこ
れらは一例にすぎず、他の化学的類似方法によつても製
造されるものである。Next, the method for producing the compound of the present invention will be explained, but these are only examples, and the compound can also be produced by other chemically similar methods.
尚、出発原料であるシス及びトランス体のシクロヘキサ
ンカルボン酸誘導体は特願昭52−・7263λ特願昭
53−4608の方法によつて収率よく得ることが出来
る。The starting materials, cis and trans cyclohexanecarboxylic acid derivatives, can be obtained in good yields by the method disclosed in Japanese Patent Application No. 52-7263λ and Japanese Patent Application No. 53-4608.
製造法
一般式(■)て表わされる化合物に一般式(■)で表わ
されるシクロヘキサンカルボン酸誘゛導体の反応性誘導
体を反応させる方法。Production method A method in which a compound represented by the general formula (■) is reacted with a reactive derivative of a cyclohexanecarboxylic acid derivative represented by the general formula (■).
当該製造法に就いて更に詳細に説明すると、一般式(■
)で表わされるアミン類に一般式(■)で表わされるシ
クロヘキサンカルボン酸誘導体の反応性誘導体(例えば
酸ハライド、エステル誘導体、酸無水物)をテトラヒド
ロフラン、アセトン、クロロホルム、ピリジン、ベンゼ
ン、トルエン等の有機溶媒中反応させればよい。To explain the manufacturing method in more detail, the general formula (■
) to the amines represented by general formula (■) (e.g., acid halides, ester derivatives, acid anhydrides), organic compounds such as tetrahydrofuran, acetone, chloroform, pyridine, benzene, toluene, etc. The reaction may be carried out in a solvent.
又、酸ハライドを使用する場合は脱酸剤(例えばトリメ
チルアミン、トリエチルアミン、N−ジメチルアニリン
、ピリジン、炭酸ナトリウム、炭酸カリウム等)を使用
すれば反応は速やかに進行する。又、当該方法で得られ
たシクロヘキサンカルボン酸アミド誘導体のうちエステ
ル体は所望により更に加水分解することが出来る。加水
分解は水、酢酸、メタノール、エタノール及び水とアル
コール類、水ξ酢酸等の混合溶媒中、酸(例えば塩酸、
硫酸等)又はアルカリ(例えば水酸化カリウム、水酸化
ナトリウム等)の存在下に、室温又は加熱下に反応させ
ればよい。反応条件は使用する溶媒、酸又はアルカリの
量及び温度によつて適宜選択される。以下に実施例を示
し、本発明を更に具体的に説明する。Further, when using an acid halide, the reaction proceeds quickly by using a deoxidizing agent (for example, trimethylamine, triethylamine, N-dimethylaniline, pyridine, sodium carbonate, potassium carbonate, etc.). Further, among the cyclohexanecarboxylic acid amide derivatives obtained by this method, the ester form can be further hydrolyzed if desired. Hydrolysis is carried out using an acid (e.g. hydrochloric acid,
The reaction may be carried out at room temperature or under heating in the presence of an alkali (eg, potassium hydroxide, sodium hydroxide, etc.) or an alkali (eg, potassium hydroxide, sodium hydroxide, etc.). The reaction conditions are appropriately selected depending on the solvent used, the amount of acid or alkali, and the temperature. EXAMPLES The present invention will be explained in more detail with reference to Examples below.
実施例1シス1−メチルー4−イソヘキシルシクロヘキ
サンカルボン酸4.5y1塩化チオニル5mt1ベンゼ
ン30mtの混合物を還流下3時間反応させ、次に減圧
下溶媒及び過剰の塩化チオニルを留去して得た酸クロラ
イドをアントラニル酸メチル4.5f1テトラヒドロフ
ラン30m11トリエチルアミン4m7Lの混合溶液の
中に氷冷下に滴下した。Example 1 A mixture of cis-1-methyl-4-isohexylcyclohexanecarboxylic acid 4.5y1 thionyl chloride 5mt1 benzene 30mt was reacted under reflux for 3 hours, and then the solvent and excess thionyl chloride were distilled off under reduced pressure to obtain an acid. The chloride was added dropwise to a mixed solution of 4.5 fl ml of methyl anthranilate, 30 ml of tetrahydrofuran, 11 ml of triethylamine, and 4 ml of triethylamine (7 L) under ice cooling.
その後室温にて3紛、更に50℃にて3時間反応させた
。反応終了後、減圧下溶媒を留去し残渣に水を加えエー
テルで抽出した。エーテル層を水洗、脱水後エーテルを
留去した。得られた油状物を減圧蒸留すると、無色透明
の油状物N−(2−メトキシカルボニルフェニル)シス
ー1−メチル4−イソヘキシールシクロヘキサンカルボ
ン酸アミド5.7yを得た。この物質の沸点、赤外吸収
スペクトル、マススペクトル及び元素分析値は次の通り
であつた。Thereafter, 3 powders were added at room temperature, and the mixture was further reacted at 50°C for 3 hours. After the reaction was completed, the solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with ether. The ether layer was washed with water, dehydrated, and then the ether was distilled off. The obtained oil was distilled under reduced pressure to obtain 5.7y of a colorless and transparent oil N-(2-methoxycarbonylphenyl)cis-1-methyl 4-isohexylcyclohexanecarboxylic acid amide. The boiling point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows.
沸点155〜1600C/0.3順Hg赤外吸収スペク
トル νc=0(フィルム)169飄1670cm−1
マススペクトルM+359
元素分析値C22H33NO3
理論値C:73.50H:9.25N:3.90実測値
C:73.47H:9.12N:3.96実施例2シス
1−メチルー4−イソヘキシルシクレヘキサンカルボン
酸4.5y1塩化チオニル5mt1ベンゼン30m1の
混合物を還流下3時間反応させ、次に減圧下溶媒及び過
剰の塩化チオニルを留去して得た酸クロライドをアント
ラニル酸4.1y1テトラヒドロフラン30mt1トリ
エチルアミン4ntの混合溶液の中に氷冷下に滴下した
。Boiling point 155-1600C/0.3 order Hg infrared absorption spectrum νc=0 (film) 169cm 1670cm-1
Mass spectrum M+359 Elemental analysis value C22H33NO3 Theoretical value C: 73.50H: 9.25N: 3.90 Actual value C: 73.47H: 9.12N: 3.96 Example 2 cis 1-methyl-4-isohexylcyclohexane A mixture of 4.5y of carboxylic acid, 5 mt of thionyl chloride, 30 ml of benzene was reacted under reflux for 3 hours, and then the solvent and excess thionyl chloride were distilled off under reduced pressure. It was added dropwise into the mixed solution under ice cooling.
その後室温にて7時間反応させた。反応終了後、減圧下
溶媒を留去し残渣に水及び希塩酸を加え弱酸性となし、
工ーテルで抽出した。エーテル層を水洗、脱水後、減圧
留去し得られた残渣をシリカゲルを充填したカラムに吸
着させクロロホルムで展関し、溶出液を減圧留去すると
、白色結晶のN−(2−カルボキシフェニル)シスー1
−メチルー4−イソヘキシルシクロヘキサンカルボン酸
アミド3.8yを得た。この物質の融点、赤外吸収スペ
クトル、マススペクトル及び元素分析値は次の通りであ
つた。Thereafter, the mixture was allowed to react at room temperature for 7 hours. After the reaction, the solvent was distilled off under reduced pressure and water and diluted hydrochloric acid were added to the residue to make it weakly acidic.
Extracted with extractor. The ether layer was washed with water, dehydrated, and then evaporated under reduced pressure. The resulting residue was adsorbed onto a column packed with silica gel and expanded with chloroform, and the eluate was evaporated under reduced pressure to form white crystals of N-(2-carboxyphenyl)cis. 1
-Methyl-4-isohexylcyclohexanecarboxylic acid amide 3.8y was obtained. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows.
融点111〜113析c赤外吸収スペクトル νc=O
(KBr)1705、16邸d−1マススペクトルM+
345
元素分析値C2lH3lNO3
理論量C:73.01H:9.04N:4.05実測値
C:73.06H:9.01N:4.09実施例3トラ
ンス1−メチルー4−イソヘキシルシクロヘキサンカル
ボン酸4.5y1塩化チオニル5m1、ベンゼン30m
1の混合物を還流下3時間反応させ次に減圧下溶媒及び
過剰の塩化チオニルを留去して得た酸クロライドをアン
トラニル酸4.1y1テトラヒドロフラン30m1、ト
リエチルアミン4mLの混合溶液の中に室温下に滴下し
た。Melting point 111-113 analysis c infrared absorption spectrum νc=O
(KBr) 1705, 16 house d-1 mass spectrum M+
345 Elemental analysis value C2lH3lNO3 Theoretical amount C: 73.01H: 9.04N: 4.05 Actual value C: 73.06H: 9.01N: 4.09 Example 3 Trans 1-methyl-4-isohexylcyclohexanecarboxylic acid 4 .5y1 thionyl chloride 5ml, benzene 30m
The mixture of 1 was reacted under reflux for 3 hours, then the solvent and excess thionyl chloride were distilled off under reduced pressure, and the acid chloride obtained was added dropwise at room temperature to a mixed solution of anthranilic acid 4.1y1, 30 ml of tetrahydrofuran, and 4 ml of triethylamine. did.
その後室温にて7時間反応させた。反応終了後、減圧下
に溶媒を留去し残渣に水及ひ希塩酸を加え弱酸性となし
、析出する結晶をp取してメタノールより再結晶すると
、無色プリズム晶のN−(2−カルボキシフェニル)ト
ランスー1−メチルー4−イソヘキシルシクロヘキサン
カルボン酸アミド4.9yを得た。この物質の融点、赤
外吸収スペクトル、マススベクトル及び元素分析値は次
の通りであつた。Thereafter, the mixture was allowed to react at room temperature for 7 hours. After the reaction, the solvent was distilled off under reduced pressure, water and dilute hydrochloric acid were added to the residue to make it weakly acidic, and the precipitated crystals were collected and recrystallized from methanol to form colorless prism crystals of N-(2-carboxyphenyl ) 4.9y of trans-1-methyl-4-isohexylcyclohexanecarboxylic acid amide was obtained. The melting point, infrared absorption spectrum, mass vector, and elemental analysis values of this substance were as follows.
融点139〜1400C赤外吸収スペクトル νc=0
(KBr)1702、1655cm−1マススペククト
ルM+345
元素分析値C2lH3lNO3
理論値C:73.01H:9.04N:4.05実測値
C:72.95H:9.08N:4.01実施例4トラ
ンス1−メチルー4−イソヘキシルシクロヘキサンカル
ボン酸4.5y1塩化チオニル5m1、ベンゼン30m
tの混合物を還流下3時間反応させ次に減圧下溶媒及び
過剰の塩化チオニルを留去して得た酸クロライドをアン
トラニル酸メチル4.5y1テトラヒドロフラン30m
1、トリエチルアミン4m1の混合溶液の中に室温下に
滴下した。Melting point 139-1400C Infrared absorption spectrum νc=0
(KBr) 1702, 1655 cm-1 Mass spectrum M+345 Elemental analysis value C2lH3lNO3 Theoretical value C: 73.01H: 9.04N: 4.05 Actual value C: 72.95H: 9.08N: 4.01 Example 4 Trans 1-Methyl-4-isohexylcyclohexanecarboxylic acid 4.5y1 thionyl chloride 5ml, benzene 30ml
The mixture of t was reacted under reflux for 3 hours, and then the solvent and excess thionyl chloride were distilled off under reduced pressure.
1. It was dropped into a mixed solution of 4 ml of triethylamine at room temperature.
その後室温にて7時間反応させた。反応終了後、減圧下
溶媒を留去し残渣に水を加えエーテルで抽出した。エー
テル層を水洗、脱水後、減圧留去し得られた残渣をシリ
カゲルを充填したカラムに吸着させクロロホルムて展関
し、溶出液を減圧留去すると、無色プリズム晶のN−(
2−メトキシカルボニルフェニル)トランスー1−メチ
ルー4−イソヘキシルシクロヘキサンカルボン酸アミド
5.2yを得た。この物質の融点、赤外吸収スペクトル
、マススペクトル及び元素分析値は次の通りであつた。Thereafter, the mixture was allowed to react at room temperature for 7 hours. After the reaction was completed, the solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with ether. The ether layer was washed with water, dehydrated, and then evaporated under reduced pressure. The resulting residue was adsorbed onto a column packed with silica gel and expanded with chloroform. The eluate was evaporated under reduced pressure to form colorless prism crystals of N-(
5.2y of 2-methoxycarbonylphenyl)trans-1-methyl-4-isohexylcyclohexanecarboxylic acid amide was obtained. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows.
融点73〜76゜C赤外吸収スペクトル νc=0(K
Br)1696、1660cm−1マススペクトルM+
359
元素分析値C2。Melting point 73-76°C Infrared absorption spectrum νc=0(K
Br) 1696, 1660 cm-1 mass spectrum M+
359 Elemental analysis value C2.
H33NO3理論値C:73.50H:9.25N:3
.90実測値C:73.56H:9.32N:3.87
実施例5シス1−メチルー4−イソヘキシルシクロヘキ
ザンカルボン酸4.5y1塩化チオニル5m11ベンゼ
ン30m1の混合物を還流下3時間反応させ、次に減圧
下溶媒及ひ過剰の塩化チオニルを留出して得た酸クロラ
イドを5−クロルアントラニル酸3.4y1テトラヒド
ロフラン30m11トリエチルアミン4m1の混合溶液
の中に氷冷下に滴下した。H33NO3 theoretical value C:73.50H:9.25N:3
.. 90 Actual value C: 73.56H: 9.32N: 3.87
Example 5 A mixture of 4.5 y of cis-1-methyl-4-isohexylcyclohexanecarboxylic acid, 5 ml of thionyl chloride, and 30 ml of benzene was reacted under reflux for 3 hours, and then the solvent and excess thionyl chloride were distilled off under reduced pressure. The acid chloride was added dropwise to a mixed solution of 3.4y of 5-chloroanthranilic acid, 30ml of tetrahydrofuran, and 4ml of triethylamine under ice cooling.
その後室温にて7時間反応させた。反応終了後、減圧下
溶媒を留去し残渣に水及び希塩酸を加え弱酸性となし、
エーテルで抽出した。エーテル層を水洗、脱水後、減圧
留去し得られた残渣をシリカゲルを充填したカラムに吸
着させエーテルで展関し溶出液を減圧留去すると、無色
プリズム晶のN−(2ーカルボキシー4−クロルフェニ
ル)シスー1一メチルー4−イソヘキシルシクロ・\キ
サンカルボーン酸アミド3.7qを得た。この物質の融
点、赤外吸収スペクトル、マススペクトル及び元素分析
値は次の通りであつた。Thereafter, the mixture was allowed to react at room temperature for 7 hours. After the reaction, the solvent was distilled off under reduced pressure and water and diluted hydrochloric acid were added to the residue to make it weakly acidic.
Extracted with ether. The ether layer was washed with water, dehydrated, and then evaporated under reduced pressure. The resulting residue was adsorbed onto a column packed with silica gel, expanded with ether, and the eluate was evaporated under reduced pressure to form colorless prism crystals of N-(2-carboxy-4-chlorophenyl). ) 3.7q of cis-1-methyl-4-isohexylcyclo\xanecarboxylic acid amide was obtained. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows.
融点112〜113℃赤外吸収スペクトル νc=0(
KBr)1700..11680cm−1マススペクト
ルM+379
元素分析値C2lH3OClNO3
理論値C:66.39H:7.96N:3.69実測値
C:66.43H:7.92N:3.65実施例6シス
1−メチルー4−イソヘキシルシクロヘキサンカルボン
酸4.5y1塩化チオニル5m1、ベンゼン30m1の
混合物を還流下3時間反応させ、次に減圧下溶媒及び過
剰の塩化チオニルを留去して得た酸クロライドを2−ア
ミノニコチン酸2.76f1アセトン60m1、トリエ
チルアミン4mtの混合物の中に室温下に滴下した。Melting point 112-113℃ Infrared absorption spectrum νc=0(
KBr) 1700. .. 11680cm-1 Mass spectrum M+379 Elemental analysis value C2lH3OClNO3 Theoretical value C: 66.39H: 7.96N: 3.69 Actual value C: 66.43H: 7.92N: 3.65 Example 6 cis 1-methyl-4-iso A mixture of 4.5y of hexylcyclohexanecarboxylic acid, 5ml of thionyl chloride, and 30ml of benzene was reacted under reflux for 3 hours, and then the solvent and excess thionyl chloride were distilled off under reduced pressure. 76f1 was added dropwise to a mixture of 60 ml of acetone and 4 mt of triethylamine at room temperature.
その後室温にて7時間反)応させた。反応終了後、減圧
下に溶媒を留去し、残渣に水及び希塩酸を加え弱酸性と
なし、析出する結晶を淵取してメタノ−ルーイソプロピ
ルエーテルの混合溶媒より再結晶すると、無色プリズム
晶のN−(3−カルボキシー2−ピリジル)シスニー1
−メチルー4−イソー・キシルシクロヘキサンカルボン
酸アミド4.3yを得た。この物質の融点、赤外吸収ス
ペクトル、マススペクトル及び元素分析値は次の通りて
あつた。Thereafter, the reaction was allowed to proceed at room temperature for 7 hours. After the reaction, the solvent is distilled off under reduced pressure, water and dilute hydrochloric acid are added to the residue to make it weakly acidic, and the precipitated crystals are filtered out and recrystallized from a mixed solvent of methanol-isopropyl ether to form colorless prism crystals. N-(3-carboxy2-pyridyl)cisny 1
-Methyl-4-iso xylcyclohexanecarboxylic acid amide 4.3y was obtained. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows.
融点175〜177℃赤外吸収スペクトル νc=0(
KBr)1670、1650cfn−1マススペクトル
M+346
元素分析値C2OF[30N203
理論値C:69.33H:8.73N:8.09実測値
C:69.26H:8.71N:8.12以下実施例6
の方法に準じて下記の化合物を合成した。Melting point 175-177℃ Infrared absorption spectrum νc=0(
KBr) 1670, 1650cfn-1 Mass spectrum M+346 Elemental analysis value C2OF[30N203 Theoretical value C: 69.33H: 8.73N: 8.09 Actual value C: 69.26H: 8.71N: 8.12 Below Example 6
The following compound was synthesized according to the method of .
N−(2−カルボキシー4−メチルフェニル)シスー1
−メチルー4−イソヘキシルシクロヘキサンカルボン酸
アミド融点92〜94℃
N−(3・5ージクロルー4−ハイドロキシフェニル)
シスー1−メチルー4−イソヘキシルシクロヘキサンカ
ルボン酸アミド融点155〜156℃
N−(3−カルボキシー4−ハイドロキシフェニル)シ
スー1−メチルー4−イソキシルシクロヘキサンカルボ
ン酸アミド融点197〜198℃
N−(3−カルボキシー5−クロルフェニル)シスー1
−メチルー4−イソヘキシルシクロヘキサンカルボン酸
アミド融点149〜1500C
N−(3−メトキシカルボニルー2−ピリジル)シスー
1−メチルー4−イソヘキシルシクロヘキサンカルボン
酸アミド融点95〜96゜C
N−(2 −カルボキシフェニル)トランスー4−エチ
ルシクロヘキサンカルボン酸アミド融点190〜191
℃
N−(2−カルボキシフェニル)トランスー4−n−ブ
チルシクロヘキサンカルボン酸アミド融点192〜19
4℃
N−(2 −カルボキシフェニル)トランスー4−イソ
ブチルシクロヘキサンカルボン酸アミド融点170〜1
7?C
N−(2−カルボキシフェニル)トランスー4−Ter
tブチルシクロヘキサンカルボン酸アミド融点186〜
188℃
N−(2−カルボキシフェニル)トランスー4−n−ペ
ンチルシクロヘキサンカボン酸アミド融点176〜17
7℃
N−(2−カルボキシフェニル)トランスー4−イソヘ
キシルシクロヘキサンカルボン酸アミド融点180〜1
87CN-(2-carboxy4-methylphenyl)cis-1
-Methyl-4-isohexylcyclohexanecarboxylic acid amide Melting point 92-94°C N-(3,5-dichloro-4-hydroxyphenyl)
Cis-1-methyl-4-isohexylcyclohexanecarboxylic acid amide Melting point 155-156°C N-(3-carboxy-4-hydroxyphenyl)cis-1-methyl-4-isoxylcyclohexanecarboxylic acid amide Melting point 197-198°C N-(3- Carboxy-5-chlorophenyl)cis-1
-Methyl-4-isohexylcyclohexanecarboxylic acid amide melting point 149-1500C N-(3-methoxycarbonyl-2-pyridyl)cis-1-methyl-4-isohexylcyclohexanecarboxylic acid amide melting point 95-96°C N-(2-carboxy phenyl)trans-4-ethylcyclohexanecarboxylic acid amide melting point 190-191
°C N-(2-carboxyphenyl)trans-4-n-butylcyclohexanecarboxylic acid amide melting point 192-19
4℃ N-(2-carboxyphenyl)trans-4-isobutylcyclohexanecarboxylic acid amide melting point 170-1
7? CN-(2-carboxyphenyl)trans-4-Ter
t-butylcyclohexanecarboxylic acid amide melting point 186~
188°C N-(2-carboxyphenyl)trans-4-n-pentylcyclohexanecarboxylic acid amide Melting point 176-17
7°C N-(2-carboxyphenyl)trans-4-isohexylcyclohexanecarboxylic acid amide melting point 180-1
87C
Claims (1)
原子、水酸基、カルボキシル基又は低級アルコキシカル
ボニル基が任意の位置に1〜3個置換したフェニル基又
はピリジル基を、Rは低級アルキル基を、R^1は水素
原子又はメチル基を意味する)で表わされる新規なシク
ロヘキサンカルボン酸アミド誘導体。[Scope of Claims] 1 General Formula ▲ Numerical formula, chemical formula, table, etc. ▼ A novel cyclohexanecarboxylic acid amide derivative represented by a phenyl group or pyridyl group substituted at 1 to 3 positions, R is a lower alkyl group, and R^1 is a hydrogen atom or a methyl group.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9401178A JPS6058904B2 (en) | 1978-07-31 | 1978-07-31 | Novel cyclohexanecarboxylic acid amide derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9401178A JPS6058904B2 (en) | 1978-07-31 | 1978-07-31 | Novel cyclohexanecarboxylic acid amide derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5520738A JPS5520738A (en) | 1980-02-14 |
| JPS6058904B2 true JPS6058904B2 (en) | 1985-12-23 |
Family
ID=14098514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9401178A Expired JPS6058904B2 (en) | 1978-07-31 | 1978-07-31 | Novel cyclohexanecarboxylic acid amide derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6058904B2 (en) |
-
1978
- 1978-07-31 JP JP9401178A patent/JPS6058904B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5520738A (en) | 1980-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5826744B2 (en) | Shinkinapropionsan Ester Yudou Tino Seizou | |
| JPS58164557A (en) | New pyridyl compound | |
| KR20200042906A (en) | New anthranilic acid compounds, and Pin1 inhibitors using the same, therapeutic agents for inflammatory diseases and therapeutic agents for cancer | |
| EP0147475B1 (en) | Aminocyclohexanol derivatives having an expectorant activity, process for their preparation and pharmaceutical compositions containing them | |
| JPH059424B2 (en) | ||
| KR20200037363A (en) | New amide compounds, and Pin1 inhibitors using the same, therapeutic agents for inflammatory diseases and therapeutic agents for cancer | |
| JPS6253966A (en) | Novel pyridine derivative | |
| JPS6058904B2 (en) | Novel cyclohexanecarboxylic acid amide derivative | |
| JPS5835185A (en) | 3-methylflavone-8-carboxylic acid esters | |
| JPS6215057B2 (en) | ||
| JPS59167564A (en) | Sulfonium compound and its preparation | |
| JPS5877849A (en) | Biphenylalkylcarboxylic acid ester derivative, manufacture and medicine containing same | |
| JPS6056130B2 (en) | Novel salicylic acid derivatives | |
| JPS591474A (en) | Geranylgeranylacetamide compound having piperazine ring or salt thereof | |
| JPS6154018B2 (en) | ||
| JPS588379B2 (en) | Para-isobutylhydroatrobic acid derivative and its production method | |
| JPH0244284B2 (en) | ||
| US4313956A (en) | Novel sypathomimetic amine prodrugs | |
| SU895283A3 (en) | Method of preparing alpha-alkyl-0-oxybenzylamine derivatives or their salts | |
| JPS6039257B2 (en) | Novel ulcer therapeutic active acetic acid derivative | |
| JPS6039064B2 (en) | Novel phenyl acetate derivative | |
| WO2004043930A1 (en) | Quinoline derivatives which enhance cognition via the gaba-a receptor | |
| KR800001260B1 (en) | Method for the preparation of phenyl acetic acid ester derivatives | |
| JPS627900B2 (en) | ||
| JPS6019737B2 (en) | Novel anthranilic acid derivative |